Takhzyro (LANADELUMAB-FLYO) 150MG/ML INJ, syringe,2ML, NDC: 47783-0646-01
Ended Awarded Last action
- Contract number
- 36C26124N0588
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $215,511
Award facts
- Contract value 100% obligated
- $215,511.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,831 | |
| Original award | $221,342 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of the global pharmaceutical company Takeda Pharmaceutical Company Limited, for the supply of the specialty medication TAKHZYRO (lanadelumab-flyo) 150mg/2mL injection. The $215,511.40 contract is part of the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule 61-IB and will provide the critical treatment to VA medical facilities until the order's completion date of May 15, 2024. This delivery order is not designated as a set-aside contract. Takeda Pharmaceutical Company Limited, the parent organization, is a key pharmaceutical supplier to various federal agencies, including the Department of Defense and the National Institutes of Health, through its specialized product portfolio and Indefinite Delivery/Indefinite Quantity (IDV) contracts.
Quick answers
Who was awarded contract 36C26124N0588?
36C26124N0588 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 15, 2024.
How much is contract 36C26124N0588 worth?
The government has obligated $215,511 on 36C26124N0588.
Is contract 36C26124N0588 an order under another contract?
Yes. 36C26124N0588 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0588 competed?
The extent of competition for 36C26124N0588 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award